Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.
CDMO Cambrex started construction on a new R&D facility at its Milan, Italy site. The $30 million investment adds advanced analytical development and process R&D capabilities.
The partnership gives Asahi Kasei a foothold for expanding its electrolyte technology to the Chinese market.
The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.
Sasol commissioned Envision Energy for a green hydrogen design study at Sasolburg, evaluating renewables, storage, and electrolysers to produce eMethanol and sustainable aviation fuel.
In a stagnant European market, chemical distribution is evolving from an efficiency lever into a strategic growth partner.
Univar Solutions has acquired Interpur Chemicals, a leading distributor of polyurethanes and powder coatings in Europe.
New 12.5% US tariffs push Scienceindustries to urge a swift Swiss-US bilateral economic agreement to protect chemical, pharma, and life sciences trade.
The partners will combine their unique capabilities to jointly develop, offer, and deliver integrated services in the Antibody-Drug Conjugates (ADC) segment for the global pharmaceutical and biotechnology industries.
The project represents a major milestone in the industrial deployment of Catalyxx’s technology and has been recognized as a Project of National Interest (PIN) by the Portuguese Government.
The next phase of expansion for the Greenfield project in Sisslerfeld (Eiken, Switzerland) will be carried out as part of a strategic partnership. The total investment amounts to more than 500 million CHF.
Fully integrated production in Mobile, Alabama (USA) strengthens supply reliability in the Americas. Completion of backward integration across hubs in Mobile, Antwerp, and Singapore enhances global competitiveness.
Agreement advances new therapies through Engitix’s unique focus on the extracellular matrix (ECM).
An exclusive distribution agreement for Evonik Rexim amino acids strengthens Brenntag's role in the biopharma and API markets.
PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.
Despite positive elements, the ETS revision proposal risks cutting industry, not emissions.
DCAT reports that FDA has selected seven companies for its new PreCheck Pilot Program, designed to encourage US-based drug manufacturing through earlier engagement and a more predictable regulatory path.
As Managing Director, Lisa will provide strategic leadership for BASF in the UK, supporting the company’s licence to operate and ensuring the business continues to contribute to BASF’s long-term success.
Ovomas, a start-up from Ecuador, creates high-value pharmaceutical products from eggshell waste, including high-purity calcium citrate, nutraceutical capsules, and vitamin-enriched gummies.
Air Liquide is investing over $160 million to build a new Arizona facility supplying ultra-high-purity gases, including low-carbon hydrogen, to a leading chipmaker's fab expansion, starting operations in 2028.
Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.
Shell has agreed to sell its Sprng Energy renewables business in India to Aditya Birla Renewables for $1.8 billion, as part of its strategy to streamline and improve returns in its power portfolio.
Fujifilm Biotechnologies' Holly Springs, NC facility has been chosen as one of seven participants in the FDA's PreCheck Pilot Program, aimed at strengthening US pharmaceutical manufacturing and regulatory readiness.
Syensqo has broken ground on a multi-million-dollar expansion at its Havre de Grace, MD site, boosting capacity by over 30% to meet growing aerospace demand for structural adhesives and surfacing products.
Innexis plans to acquire the multi-user facility in Kundl, Tyrol, from Novartis.
Ineos and Recuro have signed a Memorandum of Understanding to develop a state-of-the-art advanced recycling facility at Ineos’ Bamble polymer site in Norway.
Evonik is modernizing the API production at its Tippecanoe site in the US Over the next five years, the company will invest $100 million in upgrading key plant components.
New capabilities help product development teams move from product goals to suggested experiments in minutes, with stronger predictive models behind the workflow.
Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.
Berlin start-up company Ucaneo brings industrial-scale carbon removal online just 18 months after groundbreaking.
Exære wins the From Lab to Market Challenge 2026 with technology to recover rare earth elements from e-waste. ESILIB and CarboNano.EU also placed; ReduCO2 took the CHEManager special award.
Russell Thomas, who has held senior roles at both organisations, takes on the joint CSO position as Symeres and Axxam push to offer clients a single pipeline spanning target screening to IND-ready drug candidates.
The goal is to tailor the business optimally to the specific requirements of the US market. Ruveon will focus on all aspects of the US glyphosate business.
Rentschler Biopharma has appointed Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.
The Coatings transaction between Carlyle and BASF, announced on October 10, 2025, was completed on June 30, 2026.
